CN Stock MarketDetailed Quotes

688799 Hunan Warrant Pharmaceutical

Watchlist
  • 39.96
  • +0.81+2.07%
Market Closed Aug 28 15:00 CST
3.75BMarket Cap16.88P/E (TTM)

Hunan Warrant Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
4.38%372.9M
10.84%1.43B
13.89%1.06B
21.74%721.05M
22.36%357.27M
12.74%1.29B
14.97%926.99M
14.02%592.31M
23.12%291.97M
20.61%1.15B
Operating revenue
4.38%372.9M
10.84%1.43B
13.89%1.06B
21.74%721.05M
22.36%357.27M
12.74%1.29B
14.97%926.99M
14.02%592.31M
23.12%291.97M
20.61%1.15B
Total operating cost
4.65%321.93M
8.88%1.21B
10.52%887.21M
18.93%604.89M
20.34%307.62M
13.08%1.11B
15.15%802.78M
13.26%508.6M
23.04%255.64M
23.54%982.74M
Operating cost
-2.96%133.12M
20.89%504.55M
27.13%373.25M
43.13%263.33M
40.16%137.19M
31.82%417.38M
36.33%293.6M
27.22%183.98M
48.13%97.88M
22.02%316.63M
Operating tax surcharges
10.34%3.33M
14.09%19.28M
18.36%11.88M
6.52%6.72M
23.62%3.01M
20.22%16.9M
6.87%10.03M
-4.14%6.31M
-23.12%2.44M
11.57%14.05M
Operating expense
12.04%138.26M
-3.51%528.1M
-7.13%382.78M
-4.79%252.48M
-4.80%123.4M
2.50%547.31M
5.84%412.16M
8.88%265.17M
21.01%129.62M
25.55%533.96M
Administration expense
22.44%16.97M
38.22%67.25M
41.73%46.9M
36.63%29.82M
32.92%13.86M
-6.43%48.65M
-15.34%33.09M
0.48%21.83M
-22.33%10.42M
48.70%52M
Financial expense
-335.72%-1.17M
-62.07%-12.32M
32.79%-3.22M
21.69%-2.15M
78.21%-269.42K
-92.05%-7.6M
-92.33%-4.8M
-1,074.75%-2.74M
-338.47%-1.24M
-648.85%-3.96M
-Interest Income (Financial expense)
-151.04%-1.15M
-71.79%-12.44M
28.19%-2.98M
34.33%-1.78M
-343.44%-456.44K
-74.00%-7.24M
-60.60%-4.16M
-498.15%-2.71M
58.32%-102.93K
-386.04%-4.16M
Research and development
3.29%31.43M
16.37%103.18M
28.86%75.64M
60.63%54.69M
84.33%30.43M
26.57%88.67M
26.49%58.7M
3.82%34.05M
-9.60%16.51M
10.05%70.06M
Credit Impairment Loss
-680.79%-1.1M
31.34%-1.58M
107.79%165.15K
21.46%-316.81K
131.36%188.57K
-39.74%-2.3M
-123.38%-2.12M
0.79%-403.39K
-274.99%-601.27K
27.42%-1.65M
Asset Impairment Loss
-24.40%-1.16M
-67.55%-7.59M
-198.80%-5.17M
-3,732.55%-3.01M
-2,489.52%-932.1K
-67.76%-4.53M
-1,246.94%-1.73M
-117.79%-78.59K
-94.92%39.01K
6.86%-2.7M
Other net revenue
Invest income
-266.89%-2.85M
-55.06%3.58M
-82.41%1.59M
-59.73%2.82M
-42.02%1.71M
367.29%7.98M
956.45%9.02M
648.54%7.01M
746.04%2.94M
127.12%1.71M
-Including: Investment income associates
-136.21%-2.9M
-5.91%-5.04M
-135.96%-3.94M
-105.96%-1.67M
-2.88%-1.23M
-86.18%-4.76M
10.00%-1.67M
56.83%-810.58K
-5,024.61%-1.2M
59.96%-2.56M
Asset deal income
--0
--200.27
100.03%200.27
100.16%200.27
100.91%200.27
----
-395.76%-673.9K
-83.33%-121.45K
---21.94K
-1,954.08%-180.01K
Other revenue
639.58%21.55M
47.68%19.95M
18.27%10.78M
76.71%9.89M
133.23%2.91M
-35.24%13.51M
-44.48%9.11M
-59.78%5.6M
-89.30%1.25M
21.36%20.86M
Operating profit
25.96%67.42M
20.97%237.11M
27.62%175.88M
31.17%125.55M
34.00%53.52M
7.76%196M
11.79%137.81M
15.26%95.71M
-4.95%39.94M
13.06%181.89M
Add:Non operating Income
-86.40%1.71K
-39.81%58.41K
-49.90%36.99K
-65.34%24.59K
580.70%12.59K
-72.20%97.05K
-76.83%73.83K
2,187.97%70.93K
854.27%1.85K
-90.67%349.08K
Less:Non operating expense
-58.67%7.33K
540.46%7.29M
1,718.65%5.58M
2,578.06%5.46M
-82.30%17.74K
-48.46%1.14M
-90.45%306.77K
-93.65%203.86K
-96.88%100.24K
1,497.11%2.21M
Total profit
25.96%67.41M
17.91%229.88M
23.81%170.34M
25.67%120.11M
34.31%53.52M
8.29%194.96M
14.29%137.58M
19.72%95.58M
2.66%39.85M
9.45%180.03M
Less:Income tax cost
67.31%14.78M
70.78%36.84M
32.35%25.66M
20.81%16.84M
53.52%8.83M
11.95%21.57M
13.22%19.39M
30.68%13.94M
7.87%5.75M
-0.93%19.27M
Net profit
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
14.46%118.19M
18.03%81.64M
1.83%34.09M
10.85%160.76M
Net profit from continuing operation
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
--118.19M
18.03%81.64M
1.83%34.09M
10.85%160.76M
Less:Minority Profit
-62.06%-7.42M
-94.19%-18.28M
-128.51%-13.59M
-309.92%-8.94M
---4.58M
---9.42M
---5.95M
---2.18M
----
----
Net profit of parent company owners
21.90%60.05M
15.60%211.32M
27.49%158.27M
33.87%112.21M
44.50%49.26M
13.71%182.8M
20.22%124.14M
21.19%83.82M
1.83%34.09M
10.85%160.76M
Earning per share
Basic earning per share
20.75%0.64
15.38%2.25
28.03%1.69
34.83%1.2
47.22%0.53
-2.99%1.95
20.00%1.32
-9.18%0.89
-25.00%0.36
-2.43%2.01
Diluted earning per share
20.75%0.64
15.38%2.25
28.03%1.69
34.83%1.2
47.22%0.53
-2.99%1.95
20.00%1.32
-9.18%0.89
-25.00%0.36
-2.43%2.01
Other composite income
Total composite income
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
118.19M
18.03%81.64M
1.83%34.09M
10.85%160.76M
Total composite income of parent company owners
21.90%60.05M
15.60%211.32M
27.49%158.27M
33.87%112.21M
44.50%49.26M
13.71%182.8M
--124.14M
21.19%83.82M
1.83%34.09M
10.85%160.76M
Total composite income of minority owners
-62.06%-7.42M
-94.19%-18.28M
-128.51%-13.59M
-309.92%-8.94M
---4.58M
---9.42M
---5.95M
---2.18M
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 4.38%372.9M10.84%1.43B13.89%1.06B21.74%721.05M22.36%357.27M12.74%1.29B14.97%926.99M14.02%592.31M23.12%291.97M20.61%1.15B
Operating revenue 4.38%372.9M10.84%1.43B13.89%1.06B21.74%721.05M22.36%357.27M12.74%1.29B14.97%926.99M14.02%592.31M23.12%291.97M20.61%1.15B
Total operating cost 4.65%321.93M8.88%1.21B10.52%887.21M18.93%604.89M20.34%307.62M13.08%1.11B15.15%802.78M13.26%508.6M23.04%255.64M23.54%982.74M
Operating cost -2.96%133.12M20.89%504.55M27.13%373.25M43.13%263.33M40.16%137.19M31.82%417.38M36.33%293.6M27.22%183.98M48.13%97.88M22.02%316.63M
Operating tax surcharges 10.34%3.33M14.09%19.28M18.36%11.88M6.52%6.72M23.62%3.01M20.22%16.9M6.87%10.03M-4.14%6.31M-23.12%2.44M11.57%14.05M
Operating expense 12.04%138.26M-3.51%528.1M-7.13%382.78M-4.79%252.48M-4.80%123.4M2.50%547.31M5.84%412.16M8.88%265.17M21.01%129.62M25.55%533.96M
Administration expense 22.44%16.97M38.22%67.25M41.73%46.9M36.63%29.82M32.92%13.86M-6.43%48.65M-15.34%33.09M0.48%21.83M-22.33%10.42M48.70%52M
Financial expense -335.72%-1.17M-62.07%-12.32M32.79%-3.22M21.69%-2.15M78.21%-269.42K-92.05%-7.6M-92.33%-4.8M-1,074.75%-2.74M-338.47%-1.24M-648.85%-3.96M
-Interest Income (Financial expense) -151.04%-1.15M-71.79%-12.44M28.19%-2.98M34.33%-1.78M-343.44%-456.44K-74.00%-7.24M-60.60%-4.16M-498.15%-2.71M58.32%-102.93K-386.04%-4.16M
Research and development 3.29%31.43M16.37%103.18M28.86%75.64M60.63%54.69M84.33%30.43M26.57%88.67M26.49%58.7M3.82%34.05M-9.60%16.51M10.05%70.06M
Credit Impairment Loss -680.79%-1.1M31.34%-1.58M107.79%165.15K21.46%-316.81K131.36%188.57K-39.74%-2.3M-123.38%-2.12M0.79%-403.39K-274.99%-601.27K27.42%-1.65M
Asset Impairment Loss -24.40%-1.16M-67.55%-7.59M-198.80%-5.17M-3,732.55%-3.01M-2,489.52%-932.1K-67.76%-4.53M-1,246.94%-1.73M-117.79%-78.59K-94.92%39.01K6.86%-2.7M
Other net revenue
Invest income -266.89%-2.85M-55.06%3.58M-82.41%1.59M-59.73%2.82M-42.02%1.71M367.29%7.98M956.45%9.02M648.54%7.01M746.04%2.94M127.12%1.71M
-Including: Investment income associates -136.21%-2.9M-5.91%-5.04M-135.96%-3.94M-105.96%-1.67M-2.88%-1.23M-86.18%-4.76M10.00%-1.67M56.83%-810.58K-5,024.61%-1.2M59.96%-2.56M
Asset deal income --0--200.27100.03%200.27100.16%200.27100.91%200.27-----395.76%-673.9K-83.33%-121.45K---21.94K-1,954.08%-180.01K
Other revenue 639.58%21.55M47.68%19.95M18.27%10.78M76.71%9.89M133.23%2.91M-35.24%13.51M-44.48%9.11M-59.78%5.6M-89.30%1.25M21.36%20.86M
Operating profit 25.96%67.42M20.97%237.11M27.62%175.88M31.17%125.55M34.00%53.52M7.76%196M11.79%137.81M15.26%95.71M-4.95%39.94M13.06%181.89M
Add:Non operating Income -86.40%1.71K-39.81%58.41K-49.90%36.99K-65.34%24.59K580.70%12.59K-72.20%97.05K-76.83%73.83K2,187.97%70.93K854.27%1.85K-90.67%349.08K
Less:Non operating expense -58.67%7.33K540.46%7.29M1,718.65%5.58M2,578.06%5.46M-82.30%17.74K-48.46%1.14M-90.45%306.77K-93.65%203.86K-96.88%100.24K1,497.11%2.21M
Total profit 25.96%67.41M17.91%229.88M23.81%170.34M25.67%120.11M34.31%53.52M8.29%194.96M14.29%137.58M19.72%95.58M2.66%39.85M9.45%180.03M
Less:Income tax cost 67.31%14.78M70.78%36.84M32.35%25.66M20.81%16.84M53.52%8.83M11.95%21.57M13.22%19.39M30.68%13.94M7.87%5.75M-0.93%19.27M
Net profit 17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M14.46%118.19M18.03%81.64M1.83%34.09M10.85%160.76M
Net profit from continuing operation 17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M--118.19M18.03%81.64M1.83%34.09M10.85%160.76M
Less:Minority Profit -62.06%-7.42M-94.19%-18.28M-128.51%-13.59M-309.92%-8.94M---4.58M---9.42M---5.95M---2.18M--------
Net profit of parent company owners 21.90%60.05M15.60%211.32M27.49%158.27M33.87%112.21M44.50%49.26M13.71%182.8M20.22%124.14M21.19%83.82M1.83%34.09M10.85%160.76M
Earning per share
Basic earning per share 20.75%0.6415.38%2.2528.03%1.6934.83%1.247.22%0.53-2.99%1.9520.00%1.32-9.18%0.89-25.00%0.36-2.43%2.01
Diluted earning per share 20.75%0.6415.38%2.2528.03%1.6934.83%1.247.22%0.53-2.99%1.9520.00%1.32-9.18%0.89-25.00%0.36-2.43%2.01
Other composite income
Total composite income 17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M118.19M18.03%81.64M1.83%34.09M10.85%160.76M
Total composite income of parent company owners 21.90%60.05M15.60%211.32M27.49%158.27M33.87%112.21M44.50%49.26M13.71%182.8M--124.14M21.19%83.82M1.83%34.09M10.85%160.76M
Total composite income of minority owners -62.06%-7.42M-94.19%-18.28M-128.51%-13.59M-309.92%-8.94M---4.58M---9.42M---5.95M---2.18M--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg